MEDANTA — Global Health Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual income statement for Global Health, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	21,666	26,942	32,751	36,923	44,103
Cost of Revenue
Gross Profit	16,237	20,690	25,158	28,126	34,135
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	18,440	22,156	26,356	30,528	37,147
Operating Profit	3,226	4,787	6,395	6,395	6,955
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	2,806	4,493	6,271	6,473	7,150
Provision for Income Taxes
Net Income After Taxes	1,962	3,261	4,781	4,813	5,541
Minority Interest
Net Income Before Extraordinary Items
Net Income	1,962	3,261	4,782	4,814	5,565
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,962	3,261	4,782	4,814	5,565
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	7.25	12.6	17.8	19.3	20.7
Dividends per Share